Middle East Pharmaceutical Industries Co (SAU:4016) Accounts Payable: ﷼45.9 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SAU:4016 Middle East Pharmaceutical Industries Co SAU:4016
22 GF Score
Price ﷼60.70
! 3 Warning Signs
View Full Analysis

What is Middle East Pharmaceutical Industries Co Accounts Payable?

Middle East Pharmaceutical Industries Co SAU:4016 +3.23% 22 Accounts Payable is ﷼45.9 Mil as of Mar. 2026. GuruFocus rates SAU:4016 with a GF Score™ of 22/100. The stock has 3 warning signs investors should review.

Middle East Pharmaceutical Industries Co's Accounts Payable for the quarter that ended in Mar. 2026 was ﷼45.9 Mil.

Middle East Pharmaceutical Industries Co's quarterly Accounts Payable declined from Sep. 2025 (﷼51.6 Mil) to Dec. 2025 (﷼44.0 Mil) but then increased from Dec. 2025 (﷼44.0 Mil) to Mar. 2026 (﷼45.9 Mil).

Middle East Pharmaceutical Industries Co's annual Accounts Payable declined from Dec. 2023 (﷼28.0 Mil) to Dec. 2024 (﷼27.3 Mil) but then increased from Dec. 2024 (﷼27.3 Mil) to Dec. 2025 (﷼44.0 Mil).

Middle East Pharmaceutical Industries Co Accounts Payable Related Terms

Middle East Pharmaceutical Industries Co Accounts Payable Historical Data

* Premium members only.

The historical data trend for Middle East Pharmaceutical Industries Co's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Middle East Pharmaceutical Industries Co Accounts Payable Chart

Middle East Pharmaceutical Industries Co Annual Data
Trend Dec23 Dec24 Dec25
Accounts Payable
28.04 27.35 44.02

Middle East Pharmaceutical Industries Co Quarterly Data
Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 38.10 52.36 51.56 44.02 45.86
SAU:4016
22GF Score
Middle East Pharmaceutical Industries Co SAU:4016
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Middle East Pharmaceutical Industries Co Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of ﷼45.9 Mil mean?
Middle East Pharmaceutical Industries Co (SAU:4016) has a Accounts Payable of ﷼45.9 Mil as of Mar. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Middle East Pharmaceutical Industries Co and its competitors.
Is Middle East Pharmaceutical Industries Co's Accounts Payable too high?
Middle East Pharmaceutical Industries Co's current Accounts Payable is ﷼45.9 Mil. Overall, Middle East Pharmaceutical Industries Co has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Middle East Pharmaceutical Industries Co's Accounts Payable compare to ZTS and UTHR?
Middle East Pharmaceutical Industries Co's Accounts Payable of ﷼45.9 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Drug Manufacturers company?
A good Accounts Payable depends on the Drug Manufacturers industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Middle East Pharmaceutical Industries Co and its competitors. Middle East Pharmaceutical Industries Co's current Accounts Payable is ﷼45.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Middle East Pharmaceutical Industries Co stock overvalued right now?
Middle East Pharmaceutical Industries Co (SAU:4016) has a current Accounts Payable of ﷼45.9 Mil. The current Accounts Payable is ﷼45.9 Mil. Middle East Pharmaceutical Industries Co's overall GF Score™ is 22/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Middle East Pharmaceutical Industries Co (SAU:4016), the current Accounts Payable is ﷼45.9 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Middle East Pharmaceutical Industries Co Business Description

Address 8146 King Muhammad V, Sulaimaniyah, P.O. Box 4180, Riyadh, SAU, 11491
Middle East Pharmaceutical Industries Co is a holding company engaged in manufacturing medicines, medicated and non-medicated creams and gels. The company operates in Private, Public, and Export segments. Geographically, it generates the majority of its revenue from Saudi Arabia.
22GF Score

Get the complete analysis for SAU:4016

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

﷼60.70
Price